| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Munther A. Khamashta | Q73418907 |
| P2093 | author name string | Uthman I | |
| P2860 | cites work | Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant | Q24633473 |
| HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus | Q28138464 | ||
| HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups | Q28142194 | ||
| HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids | Q28190335 | ||
| Polymorphisms of DMA and DMB genes in Japanese systemic lupus erythematosus | Q74258617 | ||
| High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? | Q74423543 | ||
| Tribal and geographical variations of lupus in the Sultanate of Oman: a hospital-based study | Q77655371 | ||
| IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus | Q78008225 | ||
| A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome | Q78124733 | ||
| Genetics of antiphospholipid syndrome | Q80966546 | ||
| A new human HLA class II-related locus, DM | Q28235428 | ||
| Sequence analysis of two novel HLA-DMA alleles | Q28244646 | ||
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus | Q28290536 | ||
| Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor | Q28320184 | ||
| Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards | Q33328447 | ||
| Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. | Q33331408 | ||
| Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures | Q33336296 | ||
| The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. | Q33340382 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion | Q33354998 | ||
| Distribution and Clinical Significance of Lupus Anticoagulant and Anticardiolipin Antibody in 349 Patients with Systemic Lupus Erythematosus | Q33367127 | ||
| The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients | Q33371184 | ||
| Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study | Q33376853 | ||
| Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus | Q33384380 | ||
| Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus | Q33388232 | ||
| Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients | Q33438663 | ||
| Anticardiolipin antibodies in patients with systemic lupus erythematosus. | Q33446776 | ||
| Anticardiolipin antibodies: isotype distribution and phospholipid specificity | Q33456927 | ||
| Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations | Q33487732 | ||
| Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies | Q33488717 | ||
| Significance of IgA antiphospholipid antibodies. | Q33504231 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Ethnicity and APS. | Q34021250 | ||
| Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. | Q34296850 | ||
| Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients | Q34317605 | ||
| Association of HLA-DM polymorphism with the production of antiphospholipid antibodies | Q35553733 | ||
| HLA class II alleles and genetic predisposition to the antiphospholipid syndrome | Q35556384 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Antiphospholipid antibodies and antiphospholipid syndrome. | Q40921565 | ||
| Immunology of the antiphospholipid antibody syndrome | Q41116413 | ||
| Genetic risk factors for aPL syndrome | Q41197437 | ||
| Clinical significance of anti-beta 2-glycoprotein I antibodies. | Q41253910 | ||
| Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans | Q41442962 | ||
| How HLA-DM affects the peptide repertoire bound to HLA-DR molecules | Q41594025 | ||
| Systemic lupus erythematosus in India | Q41669597 | ||
| Characterization of the specificity of peptide binding to four DR haplotypes | Q41721570 | ||
| Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes | Q41944480 | ||
| Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE). | Q43677862 | ||
| Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype | Q43850415 | ||
| Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies | Q44305352 | ||
| HLA-DQ polymorphisms are highly selective for peptide binding interactions | Q45082483 | ||
| Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant | Q45217500 | ||
| Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies | Q45228945 | ||
| Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture | Q46430510 | ||
| Hughes syndrome: a common problem in Kuwait hospitals | Q46762056 | ||
| Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus | Q46797757 | ||
| HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus. | Q47677888 | ||
| Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome? | Q48012455 | ||
| Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors. | Q49185648 | ||
| Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages. | Q50562565 | ||
| Anticardiolipin antibodies in unselected pregnant women. Relationship to fetal outcome. | Q53400109 | ||
| Characterization of HLA-DMB polymorphism. | Q53483823 | ||
| Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders | Q57089710 | ||
| Hla—dr antigens and anticardiolipin antibodies in northern italian systemic lupus erythematosus patients | Q57754018 | ||
| Major histocompatibility complex associations with primary antiphospholipid syndrome | Q58143748 | ||
| Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups | Q61943923 | ||
| Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome | Q62733767 | ||
| HLA-DR and DQ Antigens and Anticardiolipin Antibodies in Women With Recurrent Spontaneous Abortions | Q67908130 | ||
| MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study Group | Q67968371 | ||
| Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype | Q67996516 | ||
| Should anticardiolipin tests be performed in otherwise healthy pregnant women? | Q68067463 | ||
| Prevalence & clinical associations of anticardiolipin antibodies in patients with systemic lupus erythematosus in India | Q68584035 | ||
| Antiphospholipid antibodies in a Brazilian population with systemic lupus erythematosus | Q69392979 | ||
| Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome | Q71014956 | ||
| MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus | Q71572881 | ||
| Histocompatibility genes in antiphospholipid antibody syndrome | Q71683313 | ||
| Clinical features associated with a positive anticardiolipin antibody in Irish patients with systemic lupus erythematosus | Q71731363 | ||
| Association between HLA class II antigens and primary antiphospholipid syndrome from the south of Spain | Q72279361 | ||
| Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies | Q72776795 | ||
| Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus | Q72780893 | ||
| Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome | Q73029368 | ||
| Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus | Q73076870 | ||
| Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders | Q73090797 | ||
| Lack of association of beta2-glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications | Q73152598 | ||
| Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE) | Q73262423 | ||
| High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon | Q73328416 | ||
| HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients | Q73395887 | ||
| The G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in Mexican mestizo patients with primary antiphospholipid syndrome | Q73567845 | ||
| Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes | Q73574482 | ||
| Lupus anticoagulants: strong association with the major histocompatibility complex class II and platelet antibodies | Q73614975 | ||
| HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus | Q73737702 | ||
| Anticardiolipin antibodies: importance, controversies, discrepancies; the need for guidelines and calibrators | Q74021870 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1671-1676 | |
| P577 | publication date | 2005-05-26 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Ethnic and geographical variation in antiphospholipid (Hughes) syndrome | |
| P478 | volume | 64 |
| Q80565313 | A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome |
| Q33406095 | Antiphospholipid antibodies in iraqi women with recurrent mid-trimester abortions |
| Q83008761 | Antiphospholipid syndrome |
| Q33375598 | Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients |
| Q38113521 | Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. |
| Q45932087 | Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. |
| Q61840758 | High Frequency of Anti-Protein Z IgM and IgG Autoantibodies in Women with Idiopathic Recurrent Spontaneous Miscarriage |
| Q33259079 | Is admission for epistaxis more common in Caucasian than in Asian people? A preliminary study |
| Q36458164 | Laboratory diagnosis and management challenges in the antiphospholipid syndrome |
| Q33378048 | Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients |
| Q37523338 | The role of ethnicity, age and gender in venous thromboembolism |
Search more.